We would love to hear your thoughts about our site and services, please take our survey here.
TYK" JAK1 at it again, bit of heavy reading..
https://www.sciencedirect.com/science/article/pii/S2212137421000555
Looking forward to our news flow, not long now ;)
Good morning, bit of light reading
https://kalkinemedia.com/uk/stocks/healthcare/100-300-return-in-a-year-should-you-buy-these-2-aim-stocks
Muppets need to be in it to reap it
Dimwit needs to eat more WOTSITS, stick to the wee little ones till you gob can cope with Giant ones;)
Great research guys and welcome aboard cuvio, intellect is very welcome on this board, whatever your entry price ;)
Keep up the great work Citizen, here are a couple more for you and our dedicated researchers
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00435-7/fulltext
https://www.mdpi.com/1422-0067/22/21/11322/htm
And we continue to patently study ;)
6min in. for the believers in charts
https://www.share-talk.com/traders-cafe-with-zak-mir-bulletin-board-heroes-monday-18th-october-2021-via-vox-markets/#gs.dfc5ol
Someone mentioned Patent news updated on Tuesday's, FOMO must be nearing Halloween ;)
Very true Danny, only overlooked by fly by's
I have no idea how to value Sareum's molecules, especially with this complex patent... But one thing is for sure the WORLD will know soon enough ;)
I really hope Sareum explain the patent and its potential in layman's when the RNS is delivered.
GLALTH's ;)
Again fantastic research and postings this weekend, Sareum's time is now, very very exciting well done to all the LTH's who have kept the faith ;)
week or so ago, already posted before, Were here and ready to rattle a few cages;)
"a setback for an experimental medicine that Wall Street expects to generate billions of dollars in sales."
https://www.biopharmadive.com/news/bristol-myers-deucravacitinib-tyk2-ulcerative-colitis/607855/
https://clinicaltrials.gov/ct2/show/NCT05076006
Hope it works, my Friar Tucks getting bigger, I need some now!!
WIP
Recent delays in compound supply mean that SDC-1801 is now scheduled to commence its final preclinical studies at the beginning of Q4 2021 but the Company still aims to file a Clinical Trial Application (CTA) by the end of Q4, subject to no further delays. First clinical trials - safety studies in healthy volunteers - may commence in early 2022, subject to gaining the requisite approval and funding.
News could drop on many fronts any time,
Chinese whispers..
Secret talks....
Secret patent..
Growing old...
Hold for GOLD...
Don't let go...
10 outa 10 here we go
That was SO long ago!
Licencing deals or T/O who knows
We got the molecules and ready to go go go
Wombles from Wimbledon that were full off carp
With their hands glued to tarmac
and feeling real trapped ;)
Just let em join the que to get some FUEL!!! ;)
Couldn't help myself:) hope all are well, enjoy the weekend, giblets gibbering, next few months will be very interesting ;)
https://www.biospace.com/article/releases/ventyx-biosciences-announces-key-appointments-and-closing-of-51-0-million-series-b-convertible-preferred-stock-financing-round/
RNS could land anytime, and we continue to wait patiently ;)
Precision Oncology with Drugs Targeting the Replication
Stress, ATR, and Schlafen 11
sums it up from MDPI article, even they have noted the lagging development, surely the new terms must have had timescales Sierra need to meet?
6. Conclusions and Perspectives
Targeting DNA replication, checkpoints, and repair pathways are promising approaches for cancer treatment. A rich portfolio of drugs is in development, especially
targeting ATR. Although the CHK1 inhibitors UCN-01 (7-hydroxystaurosprine), SRA737,
and prexasertib preceded the ATR inhibitors, their development is lagging. It is plausible
that the successful development of the ATR and WEE1 inhibitors will generate a renewed
interest in CHK1 inhibitor
https://www.msn.com/en-gb/news/world/five-children-orphaned-after-both-parents-die-of-covid/ar-AAOoLpN?ocid=entnewsntp
36 & 37, very very sad, covid or cancer, its why were invested. lets hope the BOD's get the trials underway sooner rather than later. Nobody wants to read these awful events.
https://www.mdpi.com/2218-273X/11/9/1327/htm
I can see T2's 1+1 = 28p for starters ;)
if it works 28 quid !!
skim read:
4. Role of Proinflammatory Cytokines in Inflammation-Induced Muscle Wasting
In depth read, but shhhhh,
Sepsis - Muscle wasting - Inflammation - Cytokine - oh and Tyk2 all mentioned ;)
Have a good weekend everyone, and big thanks to the great posters on this board. Keep up the great work